These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 312108)

  • 1. Trimethoprim and sulphamethoxazole inhibition of haematopoiesis in vitro.
    Golde DW; Bersch N; Quan SG
    Br J Haematol; 1978 Nov; 40(3):363-7. PubMed ID: 312108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies of the effects of trimethoprim and sulfamethoxazole on human granulopoiesis.
    Bjornson BH; McIntyre AP; Harvey JM; Tauber AI
    Am J Hematol; 1986 Sep; 23(1):1-7. PubMed ID: 3488680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-fluorocytosine: inhibition of hematopoiesis in vitro and reversal of inhibition by uracil.
    Koeffler HP; Golde DW
    J Infect Dis; 1979 Apr; 139(4):438-43. PubMed ID: 438544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of trimethoprim on leukaemic cells in vitro.
    Rivard GE; Momparler LF; Momparler RL
    Br J Haematol; 1981 Feb; 47(2):221-6. PubMed ID: 6970589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of sulphonamide-trimethoprim combinations for urinary tract infections. Part 3: Pharmacokinetic characterization of sulphadiazine and sulphamethoxazole given with trimethoprim.
    Ortengren B; Magni L; Bergan T
    Infection; 1979; 7 Suppl 4():S371-81. PubMed ID: 511351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitivity of Pseudomonas aeruginosa to sulphonamides and trimethoprim and the activity of the combination trimethoprim: sulphamethoxazole.
    Grey D; Hamilton-Miller JM
    J Med Microbiol; 1977 Aug; 10(3):273-9. PubMed ID: 408490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-trimoxazole sensitivity testing: comparison of separate and combined disk agar diffusion techniques.
    Amyes SG; Telfer Brunton WA
    J Clin Pathol; 1981 Feb; 34(2):199-202. PubMed ID: 7229100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-vitro and in-vivo studies of trimethoprim-sulphamethoxazole against multiple resistant Staphylococcus aureus.
    Yeldandi V; Strodtman R; Lentino JR
    J Antimicrob Chemother; 1988 Dec; 22(6):873-80. PubMed ID: 3266621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sulphamethoxazole-trimethoprim: effect on antibody response in man.
    Arvilommi H; Vuori M; Salmi A
    Chemotherapy; 1976; 22(1):37-42. PubMed ID: 1253629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of thymidine uptake of human lymphocytes by co-trimoxazole.
    Gaylarde PM; Sarkany I
    Br Med J; 1972 Jul; 3(5819):144-6. PubMed ID: 5039776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combinations of antimicrobial agents. III. The in vitro sensitivity of 12 strains of Pseudomonas aeruginosa and 12 strains of proteus species ot sulphamethoxazole + trimethoprim (co-trimoxazole), polymyxins and combinations of co-trimoxazole and polymyxins.
    Kuipers JS
    Arch Chir Neerl; 1976; 28(2):91-9. PubMed ID: 823875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibility of Branhamella catarrhalis to sulphamethoxazole and trimethoprim.
    Riley TV; Digiovanni C; Hoyne GF
    J Antimicrob Chemother; 1987 Jan; 19(1):39-43. PubMed ID: 3494008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure to demonstrate an advantage in combining sulphamethoxazole with trimethoprim in an experimental model of urinary infection.
    Anderson JD; Lacey RW; Lewis EL; Sellin MA
    J Clin Pathol; 1974 Aug; 27(8):619-22. PubMed ID: 4425219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of trimethoprim (TMP), sulphamethoxazole (SMX) and the combination against Bacteroides fragilis group isolates.
    Jackson-York GL; Gump BB; Gump DW
    J Antimicrob Chemother; 1983 Nov; 12(5):515-8. PubMed ID: 6671927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cotrimoxazole as an inhibitor of oxidative drug metabolism: effects of trimethoprim and sulphamethoxazole separately and combined on tolbutamide disposition.
    Wing LM; Miners JO
    Br J Clin Pharmacol; 1985 Nov; 20(5):482-5. PubMed ID: 3878154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Trimethoprim-sulphamethoxazole--a study on resistance patterns in Escherichia coli].
    Madsen ST
    Tidsskr Nor Laegeforen; 1973 Nov; 93(30):2244-5. PubMed ID: 4588011
    [No Abstract]   [Full Text] [Related]  

  • 17. Co-trimoxazole versus nafcillin in the therapy of experimental meningitis due to Staphylococcus aureus.
    Scheld WM; Keeley JM; Field MR; Brodeur JP
    J Antimicrob Chemother; 1987 May; 19(5):647-58. PubMed ID: 3497147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enforced TAL-1 expression stimulates primitive, erythroid and megakaryocytic progenitors but blocks the granulopoietic differentiation program.
    Valtieri M; Tocci A; Gabbianelli M; Luchetti L; Masella B; Vitelli L; Botta R; Testa U; Condorelli GL; Peschle C
    Cancer Res; 1998 Feb; 58(3):562-9. PubMed ID: 9458106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of nocardial infection with trimethoprim-sulphamethoxazole.
    Pavillard ER
    Med J Aust; 1973 Jun; 1(2):Suppl:65-9. PubMed ID: 4580590
    [No Abstract]   [Full Text] [Related]  

  • 20. Chromosomal studies in vivo and in vitro of trimethoprim and sulphamethoxazole (co-trimoxazole).
    Stevenson AC; Clarke G; Patel CR; Hughes DT
    Mutat Res; 1973 Feb; 17(2):255-60. PubMed ID: 4684402
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.